Browse by Title

Type here to filter the list

F
Facial Recognition to Detect Vital Physiologic Signs: The AI NEXUS Platform

Issam Moussa, MD – Carle Health / University of Illinois Urbana Champaign ### 388128###Speaker###Medical Director, Carle Heart & Vascular Institte###Carle Health / University of Illinois Urbana Champaign###
Speaker: Issam Moussa, MD – Carle Health / University of Illinois Urbana Champaign
###
Factors Related With Concordance And Discordance Between Quantitative Flow Ratio And Myocardial Perfusion Scintigraphy

Luciano Santos, MD, PhD (he/him/his) – Hospital Santa Lucia ### 2234325###Speaker###Coordinator in the Interventional Cardiology Division###Hospital Santa Lucia###
Speaker: Luciano Santos, MD, PhD (he/him/his) – Hospital Santa Lucia
### he/him/his
FAME 3 Trial Lessons Learned

William F. Fearon, MD – Stanford University School of Medicine ### 163097###Speaker###Professor of Medicine Director, Interventional Cardiology###Stanford University School of Medicine###
Speaker: William F. Fearon, MD – Stanford University School of Medicine
###
Favorable Effects Of The Altavalve Mitral Prosthesis On Left Atrium Volume And Strain

Nadira Hamid, MD – Columbia University Medical Centre / New York Presbyterian ### 1535335###Speaker###Assistant Professor###Columbia University Medical Centre / New York Presbyterian###
Speaker: Nadira Hamid, MD – Columbia University Medical Centre / New York Presbyterian
###
FDA Japan | Session One [Non-CME]

Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration ### 163054###Program Director###Deputy Director, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Program Director: Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration
### @@@ Neal E. Fearnot, PhD – Cook Group Incorporated ### 163096###Program Director###Vice President###Cook Group Incorporated###
Program Director: Neal E. Fearnot, PhD – Cook Group Incorporated
###
FDA Japan | Session Two [Non-CME]

Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration ### 163054###Program Director###Deputy Director, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Program Director: Kenneth J. Cavanaugh, Jr., PhD – U.S. Food and Drug Administration
### @@@ Neal E. Fearnot, PhD – Cook Group Incorporated ### 163096###Program Director###Vice President###Cook Group Incorporated###
Program Director: Neal E. Fearnot, PhD – Cook Group Incorporated
###
FDA Perspective

Mauro Moscucci, MD, MBA, MPH – Food and Drug Administration, Center for Devices and Radiological Health ### 914908###Speaker###Medical Officer###Food and Drug Administration, Center for Devices and Radiological Health###
Speaker: Mauro Moscucci, MD, MBA, MPH – Food and Drug Administration, Center for Devices and Radiological Health
###
FDA Perspective: Cybersecurity and Software Validation FDA Requirements in Product Development

Aneesh Deoras, MSE – U.S. Food and Drug Administration ### 1550672###Speaker###Assistant Director for Cardiac Ablation, Mapping, and Imaging Devices###U.S. Food and Drug Administration###
Speaker: Aneesh Deoras, MSE – U.S. Food and Drug Administration
###
FDA Perspective: Early Management of Software Iterative Changes in AI Products

Stephen Browning, BSE (he/him/his) – FDA/CDRH ### 692614###Speaker###Assistant Division Director, Hemodynamic and Heart Failure Diagnostic Devices###FDA/CDRH###
Speaker: Stephen Browning, BSE (he/him/his) – FDA/CDRH
### he/him/his
FDA Perspective on Innovation

Bram Zuckerman, MD – U.S. Food and Drug Administration ### 163359###Speaker###Director Office of CV Devices###U.S. Food and Drug Administration###
Speaker: Bram Zuckerman, MD – U.S. Food and Drug Administration
###
FDA Perspectives on Digital Health Apps in Cardiovascular Trials

Aneesh Deoras, MSE – U.S. Food and Drug Administration ### 1550672###Speaker###Assistant Director for Cardiac Ablation, Mapping, and Imaging Devices###U.S. Food and Drug Administration###
Speaker: Aneesh Deoras, MSE – U.S. Food and Drug Administration
###
FDA Perspectives on Periprocedural MI in Trials Intended for Regulatory Review: What Has Changed?

Lydia Glaw, PhD – US FDA ### 1546620###Speaker###Assistant Director###US FDA###
Speaker: Lydia Glaw, PhD – US FDA
###
FDA Perspectives on Regulatory Pathway Considerations, Wellness Devices, and Multiple Function Device Products

Aneesh Deoras, MSE – U.S. Food and Drug Administration ### 1550672###Speaker###Assistant Director for Cardiac Ablation, Mapping, and Imaging Devices###U.S. Food and Drug Administration###
Speaker: Aneesh Deoras, MSE – U.S. Food and Drug Administration
###
FDA Perspectives: What is the Impact of AI/Machine Learning on Medical Devices?

Stephen Browning, BSE (he/him/his) – FDA/CDRH ### 692614###Speaker###Assistant Division Director, Hemodynamic and Heart Failure Diagnostic Devices###FDA/CDRH###
Speaker: Stephen Browning, BSE (he/him/his) – FDA/CDRH
### he/him/his
FDA Valve and Structural Innovations Town Hall [Non-CME]

Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration ### 163094###Program Director###Chief Medical Officer, Office of Cardiovascular Devices###U.S. Food and Drug Administration###
Program Director: Andrew Farb, MD (he/him/his) – U.S. Food and Drug Administration
### he/him/his @@@ Nicole Ibrahim, PhD – U.S. Food and Drug Administration ### 163143###Program Director###Deputy Office Director, OCVD###U.S. Food and Drug Administration###
Program Director: Nicole Ibrahim, PhD – U.S. Food and Drug Administration
### @@@ Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 161917###Program Director###Director, Cardiovascular Research and Advanced Education###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Program Director: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
### @@@ Changfu Wu, PhD – Food and Drug Administration ### 184772###Program Director###SBRBPAS Expert###Food and Drug Administration###
Program Director: Changfu Wu, PhD – Food and Drug Administration
### @@@ Bram Zuckerman, MD – U.S. Food and Drug Administration ### 163359###Program Director###Director Office of CV Devices###U.S. Food and Drug Administration###
Program Director: Bram Zuckerman, MD – U.S. Food and Drug Administration
###
Feasibility And Outcome Of Percutaneous Repair Of Peri-infarct Vsd In The Contemporary Era: A Single Center Experience

Nathan Bugs, MD – University of Texas at Houston ### 2234346###Speaker###Resident###University of Texas at Houston###
Speaker: Nathan Bugs, MD – University of Texas at Houston
###
Feasibility And Outcome Of Percutaneous Repair Of Peri-infarct Vsd In The Contemporary Era: A Single Center Experience

Nathan Bugs, MD – University of Texas at Houston ### 2234346###Speaker###Resident###University of Texas at Houston###
Speaker: Nathan Bugs, MD – University of Texas at Houston
###
Feasibility And Periprocedural Outcomes Of Transcatheter Mass Extarction In Left Heart And Aortic Arch

Jonathan X. Fang, MBBS (he/him/his) – Henry Ford Hospital ### 1872247###Speaker###Structural heart disease fellow###Henry Ford Hospital###
Speaker: Jonathan X. Fang, MBBS (he/him/his) – Henry Ford Hospital
### he/him/his
Feasibility Of Using 3d Tee For Tmvr Pre-screening

Clare Otto ### 2275166###Speaker#########
Speaker: Clare Otto
###
Featured Clinical Science Session [Non-CME]

H. Vernon Anderson, MD – University of Texas Health Science Center ### 386919###Moderator###Professor of Medicine###University of Texas Health Science Center###
Moderator: H. Vernon Anderson, MD – University of Texas Health Science Center
### @@@ Kevin Croce, MD, PhD – Brigham and Women's Hospital ### 554776###Moderator###Director of CTO and Complex PCI Programs###Brigham and Women's Hospital###
Moderator: Kevin Croce, MD, PhD – Brigham and Women's Hospital
### @@@ Patrick W. Serruys, MD, PhD – University of Galway, Ireland ### 163289###Moderator###Professor of Medical Intervention & Innovation###University of Galway, Ireland###
Moderator: Patrick W. Serruys, MD, PhD – University of Galway, Ireland
### @@@ Khaled F. Al-Shaibi, MBChB, FACC FSCAI (he/him/his) – King Fahd Armed Forces Hospital ### 408144###Panel Discussant###Director of the Cardiac Center###King Fahd Armed Forces Hospital###
Panel Discussant: Khaled F. Al-Shaibi, MBChB, FACC FSCAI (he/him/his) – King Fahd Armed Forces Hospital
### he/him/his @@@ Israel Barbash, MD (he/him/his) – Leviev Heart Center, Sheba Medical Center ### 184729###Panel Discussant###Interventional Cardiologist###Leviev Heart Center, Sheba Medical Center###
Panel Discussant: Israel Barbash, MD (he/him/his) – Leviev Heart Center, Sheba Medical Center
### he/him/his @@@ Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine ### 163179###Panel Discussant###Professor of Medicine ###Yale School of Medicine###
Panel Discussant: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
###
FELLOWS SYMPOSIUM | IVUS 123: Applying an Algorithmic Approach to Intravascular Imaging [Non-CME; Registered Participants Only] – Sponsored by Boston Scientific Corporation
Fem-Pop Stenting: What Guides My Device Selection

Peter A. Soukas, MD, FSCAI – Cardiovascular Institute/ Brown Medical School ### 171169###Speaker###Director, Vascular Medicine & Interventional PV Lab###Cardiovascular Institute/ Brown Medical School###
Speaker: Peter A. Soukas, MD, FSCAI – Cardiovascular Institute/ Brown Medical School
###
FFR-Guided Revascularization Versus Non-FFR Guided Partial Or Complete Revascularization In Acute Myocardial Infarction: A Systematic Review And Meta-analysis

Faris Sukhon, MD – Case Western Reserve University / Metrohealth Medical Center ### 2234297###Speaker###Fellow in training###Case Western Reserve University / Metrohealth Medical Center###
Speaker: Faris Sukhon, MD – Case Western Reserve University / Metrohealth Medical Center
###
Fifty Percent of Patients with CLTI Dead at 5 Years | Why Can't We Move the Needle?

S. Elissa Altin, MD – Yale University ### 643860###Speaker###Associate Professor###Yale University###
Speaker: S. Elissa Altin, MD – Yale University
###
Final Comments & Adjourn

Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center ### 163255###Program Director###Professor and Allison Family Distinguished Chair of Cardiovascular Research###Houston Methodist DeBakey Heart & Vascular Center###
Program Director: Michael J. Reardon, MD – Houston Methodist DeBakey Heart & Vascular Center
### @@@ Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center ### 185869###Program Director###Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease###Georgetown University and MedStar Washington Hospital Center###
Program Director: Toby Rogers, MD, PhD – Georgetown University and MedStar Washington Hospital Center
###
FINAL ISSUES AND FUTURE DIRECTIONS

Edward Koifman, MD – Meir Medical Center, and Tel Aviv University, Israel ### 201945###Moderator###Director Interventional Cardiology###Meir Medical Center, and Tel Aviv University, Israel###
Moderator: Edward Koifman, MD – Meir Medical Center, and Tel Aviv University, Israel
### @@@ Michael Ragosta, MD (he/him/his) – University of Virginia ### 163251###Moderator###Director, Cardiac Catheterization Laboratory###University of Virginia###
Moderator: Michael Ragosta, MD (he/him/his) – University of Virginia
### he/him/his @@@ Robert W. Yeh, MD, MSc – Beth Israel Deaconess Medical Center ### 194547###Moderator###Professor of Medicine###Beth Israel Deaconess Medical Center###
Moderator: Robert W. Yeh, MD, MSc – Beth Israel Deaconess Medical Center
###
FINAL REFERRAL and PANEL DISCUSSION

Steven R. Bailey, MD, MSCAI – LSU Health Shreveport ### 163014###Chair###Professor and Chairman, Department of Medicine LSU Health Shreveport###LSU Health Shreveport###
Chair: Steven R. Bailey, MD, MSCAI – LSU Health Shreveport
### @@@ Israel Barbash, MD (he/him/his) – Leviev Heart Center, Sheba Medical Center ### 184729###Co-Chair###Interventional Cardiologist###Leviev Heart Center, Sheba Medical Center###
Co-Chair: Israel Barbash, MD (he/him/his) – Leviev Heart Center, Sheba Medical Center
### he/him/his @@@ Yuval Binur, PhD – Arsuf Global Partners ### 163032###Judge###Managing Partner###Arsuf Global Partners###
Judge: Yuval Binur, PhD – Arsuf Global Partners
### @@@ Sam Chitsaz, MD FACC FSCAI – Sutter Health ### 1247735###Judge###Interventional Cardiologist###Sutter Health###
Judge: Sam Chitsaz, MD FACC FSCAI – Sutter Health
### @@@ Tim A. Fischell, MD, FACC – Ascension Borgess Heart Institute ### 163101###Judge###Director of Cardiovascular Research###Ascension Borgess Heart Institute###
Judge: Tim A. Fischell, MD, FACC – Ascension Borgess Heart Institute
### @@@ Nicolas Foin, MSc, PhD – Dhenin/ Duke-NUS ### 203841###Judge###Founder/ Adj Associate Professor###Dhenin/ Duke-NUS###
Judge: Nicolas Foin, MSc, PhD – Dhenin/ Duke-NUS
### @@@ Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona ### 163137###Judge###Interventional Cardiologist###Heart and Vascular Center of Arizona###
Judge: Rich R. Heuser, MD, MSCAI – Heart and Vascular Center of Arizona
### @@@ Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center ### 235167###Judge###Director Heart Institute###Hadassah-Hebrew University Medical Center###
Judge: Chaim Shaul Lotan, MD – Hadassah-Hebrew University Medical Center
### @@@ Jonathan G. Schwartz, MD (he/him/his) – Sanger Heart & Vascular Institute/Atrium Health ### 1546638###Judge###Medical Director, Interventional Cardiology###Sanger Heart & Vascular Institute/Atrium Health###
Judge: Jonathan G. Schwartz, MD (he/him/his) – Sanger Heart & Vascular Institute/Atrium Health
### he/him/his @@@ Mark A. Turco, MD – JC Medical and Genesis MedTech ### 163321###Judge###CEO & President###JC Medical and Genesis MedTech###
Judge: Mark A. Turco, MD – JC Medical and Genesis MedTech
###
Final report—CSRC SHARC Working Group

Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute ### 161917###Speaker###Director, Cardiovascular Research and Advanced Education###MedStar Washington Hospital Center, MedStar Heart and Vascular Institute###
Speaker: Ron Waksman, MD, MSCAI – MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
###
Final Thoughts & Adjourn

Maurice Buchbinder, MD, FSCAI – Foundation for Cardiovascular Medicine ### 163045###Speaker###Medical Director###Foundation for Cardiovascular Medicine###
Speaker: Maurice Buchbinder, MD, FSCAI – Foundation for Cardiovascular Medicine
###
First In Human Case Of Left Appendage Closure Device Implantation Using A Novel Ultranav Double Lumen Catheter And Intracardiac Echocardiography Without Anesthesia Nor Tee

Nabil Dib, MD, MSc, FESC – Mercy Gilbert Medical Center/Dignity Health ### 939332###Speaker###Director Cardiovascular Research###Mercy Gilbert Medical Center/Dignity Health###
Speaker: Nabil Dib, MD, MSc, FESC – Mercy Gilbert Medical Center/Dignity Health
###
First In Human Use Of Cerebral Flow Diverting Stent To Treat A Large Coronary Aneurysm.

Chintan P. Patel, MD MPH (he/him/his) – Atria Heart, PLLC ### 2234191###Speaker###Interventional Cardiologist###Atria Heart, PLLC###
Speaker: Chintan P. Patel, MD MPH (he/him/his) – Atria Heart, PLLC
### he/him/his
First Trans-Pacific Device Classification Reconciliation (Aortic graft)

Robert Thatcher, MBA (he/him/his) – Diaxamed, LLC ### 196715###Speaker###CEO at Diaxamed###Diaxamed, LLC###
Speaker: Robert Thatcher, MBA (he/him/his) – Diaxamed, LLC
### he/him/his
First Trans-Pacific Disruptive Technology (Tricuspid valve)

Stephen M. Rowland, PhD – OrbusNeich Medical Inc. ### 163271###Speaker###Vice-President, Research and Development###OrbusNeich Medical Inc.###
Speaker: Stephen M. Rowland, PhD – OrbusNeich Medical Inc.
###
First Trans-Pacific Early Feasibility Study (Mitral valve)

Katherine Kumar, PhD, RAC – 4C Medical Technologies, Inc. ### 492584###Speaker###Sr. EVP###4C Medical Technologies, Inc.###
Speaker: Katherine Kumar, PhD, RAC – 4C Medical Technologies, Inc.
###
First Trans-Pacific Pediatric Device (Pulmonic valve)

Declan Dineen, BSc, MSc – Medtronic Inc. ### 2262547###Speaker###Vice President Regulatory Affairs###Medtronic Inc. ###
Speaker: Declan Dineen, BSc, MSc – Medtronic Inc.
###
First Trans-Pacific Single Protocol Prospective RCT (PAD) - The Zilver-PTX Stent

Neal E. Fearnot, PhD – Cook Group Incorporated ### 163096###Speaker###Vice President###Cook Group Incorporated###
Speaker: Neal E. Fearnot, PhD – Cook Group Incorporated
###
First Trans-Pacific Single Protocol RCT (CAD) - The HARMONEE Study

Shigeru Saito, MD, FACC, FSCAI – Shonan Kamakura General Hospital ### 163277###Speaker###, Director of Cardiology & Catheterization Laboratories###Shonan Kamakura General Hospital###
Speaker: Shigeru Saito, MD, FACC, FSCAI – Shonan Kamakura General Hospital
###
First-in-Man Evaluation of Intracoronary Cryotherapy for Vulnerable Plaque Stabilization

Carlos Collet, MD – OLV Aalst ### 1543973###Speaker###Co-director cath lab###OLV Aalst###
Speaker: Carlos Collet, MD – OLV Aalst
###
Five-Year Durability and Performance Evaluation of an Intra-Annular, Self-Expanding Transcatheter Heart Valve

Rishi Puri, MBBS PhD FRACP – Cleveland Clinic ### 467899###Speaker###Staff Structural and Coronary Interventionalist###Cleveland Clinic###
Speaker: Rishi Puri, MBBS PhD FRACP – Cleveland Clinic
###
Focus 2024: The “Goldilocks” Use Case Construct

Dominic Allocco, MD, MS – Boston Scientific ### 914909###Speaker###Vice President, Clinical###Boston Scientific###
Speaker: Dominic Allocco, MD, MS – Boston Scientific
###
Foldax Biopolymer Valve

Steven J. Yakubov, MD, FACC, MSCAI – OhioHealth/Riverside Methodist Hospital ### 163353###Speaker###System/Medical Chief - Structural Heart Disease###OhioHealth/Riverside Methodist Hospital###
Speaker: Steven J. Yakubov, MD, FACC, MSCAI – OhioHealth/Riverside Methodist Hospital
###
Forearm Access in CHIP

Samir B. Pancholy, MD, MSCAI – Wright Center of Graduate Medical Education, Geisinger Commonwealth School of Medicine, Scranton ### 163240###Speaker###Program Director, Fellowship in Cardiovascular Disease, Professor of Medicine###Wright Center of Graduate Medical Education, Geisinger Commonwealth School of Medicine, Scranton###
Speaker: Samir B. Pancholy, MD, MSCAI – Wright Center of Graduate Medical Education, Geisinger Commonwealth School of Medicine, Scranton
###
Fractional Flow Reserve or Optical Coherence Tomography to Guide the Management of Patients with Angiographically Intermediate Coronary Stenosis: 5-Year Clinical Outcomes Observed in the FORZA Trial

Francesco Burzotta, MD (he/him/his) – Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore ### 2238502###Speaker###Head of Cardiology Units###Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore###
Speaker: Francesco Burzotta, MD (he/him/his) – Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
### he/him/his
Frequently Asked Questions: Medical Therapies

Megha Prasad, MD – Columbia university ### 1432184###Speaker###Assistant professor###Columbia university###
Speaker: Megha Prasad, MD – Columbia university
###
From Chest Pain To Coronary Functional Testing: Clinical And Economic Impact Of Coronary Microvascular Dysfunction

Ilan Merdler, MD, MHA (he/him/his) – MedStar Washington Hospital Center ### 1810737###Speaker###Interventional Cardiology Fellow###MedStar Washington Hospital Center###
Speaker: Ilan Merdler, MD, MHA (he/him/his) – MedStar Washington Hospital Center
### he/him/his
From Clinical Trials to Clinical Practice | Symplicity Spyral RDN System

David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute ### 163153###Speaker###Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare###Piedmont Heart Institute###
Speaker: David E. Kandzari, MD, FACC, FSCAI – Piedmont Heart Institute
###
From Clinical Trials to Clinical Practice: RECOR Paradise Technology

Andrew SP Sharp, MD – University Hospital of Wales ### 952803###Speaker###Consultant Cardiologist###University Hospital of Wales###
Speaker: Andrew SP Sharp, MD – University Hospital of Wales
###
From US EFS to Pivotal Study: Industry Perspective and Case Example ECP Device

Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc ### 163295###Speaker###EVP Chief Medical Officer ###Abiomed Inc###
Speaker: Charles A. Simonton, MD, FACC, FSCAI – Abiomed Inc
###
FUNDAMENTALS OF INTRAVASCULAR IMAGING

Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center ### 163109###Moderator###Director of Invasive Imaging Core Laboratory###MedStar Washington Hospital Center###
Moderator: Hector M. Garcia-Garcia, MD, PhD – MedStar Washington Hospital Center
### @@@ Akiko Maehara, MD – Columbia University Medical Center ### 163201###Moderator###Professor###Columbia University Medical Center###
Moderator: Akiko Maehara, MD – Columbia University Medical Center
### @@@ Gary S. Mintz, MD (he/him/his) – Cardiovascular Research Foundation ### 163215###Moderator###Senior Medical Advisor###Cardiovascular Research Foundation###
Moderator: Gary S. Mintz, MD (he/him/his) – Cardiovascular Research Foundation
### he/him/his
Funding the Future – Where Are We Today? Impact of China

Yuval Binur, PhD – Arsuf Global Partners ### 163032###Speaker###Managing Partner###Arsuf Global Partners###
Speaker: Yuval Binur, PhD – Arsuf Global Partners
###